Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Langsted

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Atherosclerosis|April 28, 2024
Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trialTakahito Doi, Anne Langsted, Børge G Nordestgaard
Current Atherosclerosis Reports|March 25, 2025
Remnant Cholesterol: Should it be a Target for Prevention of ASCVD?Takahito Doi, Anne Langsted, Børge Grønne Nordestgaard
Journal of the American College of Cardiology|June 16, 2022
Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial InfarctionTakahito Doi, Anne Langsted, Børge G Nordestgaard
Journal of Atherosclerosis and Thrombosis|September 13, 2023
Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and EuropeansTakahito Doi, Anne Langsted, Børge G Nordestgaard
Journal of the American College of Cardiology|January 18, 2020
Obesity as a Causal Risk Factor for Aortic Valve StenosisMorten Kaltoft, Anne Langsted, Børge Grønne Nordestgaard
Atherosclerosis|May 22, 2023
Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortalityTakahito Doi, Anne Langsted, Børge G Nordestgaard
European Heart Journal|August 29, 2021
A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designsTakahito Doi, Anne Langsted, Børge G Nordestgaard
European Heart Journal|April 9, 2020
Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population StudyMorten Kaltoft, Anne Langsted, Børge G Nordestgaard
Current Opinion in Endocrinology, Diabetes, and Obesity|February 1, 2023
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?Takahito Doi, Børge G Nordestgaard, Anne Langsted
European Heart Journal|January 5, 2019
High lipoprotein(a) and high risk of mortalityAnne Langsted, Pia R Kamstrup, Børge G Nordestgaard
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Atherosclerosis|April 28, 2024
Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trialTakahito Doi, Anne Langsted, Børge G Nordestgaard
Current Atherosclerosis Reports|March 25, 2025
Remnant Cholesterol: Should it be a Target for Prevention of ASCVD?Takahito Doi, Anne Langsted, Børge Grønne Nordestgaard
Journal of the American College of Cardiology|June 16, 2022
Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial InfarctionTakahito Doi, Anne Langsted, Børge G Nordestgaard
Journal of Atherosclerosis and Thrombosis|September 13, 2023
Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and EuropeansTakahito Doi, Anne Langsted, Børge G Nordestgaard
Journal of the American College of Cardiology|January 18, 2020
Obesity as a Causal Risk Factor for Aortic Valve StenosisMorten Kaltoft, Anne Langsted, Børge Grønne Nordestgaard
Atherosclerosis|May 22, 2023
Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortalityTakahito Doi, Anne Langsted, Børge G Nordestgaard
European Heart Journal|August 29, 2021
A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designsTakahito Doi, Anne Langsted, Børge G Nordestgaard
European Heart Journal|April 9, 2020
Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population StudyMorten Kaltoft, Anne Langsted, Børge G Nordestgaard
Current Opinion in Endocrinology, Diabetes, and Obesity|February 1, 2023
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?Takahito Doi, Børge G Nordestgaard, Anne Langsted
European Heart Journal|January 5, 2019
High lipoprotein(a) and high risk of mortalityAnne Langsted, Pia R Kamstrup, Børge G Nordestgaard
Pageof 8